The study of iron metabolism in human phagocytes requires a continuous source of 59Fe_ labelled erythrocytes with high specific activity. Previously, rats and mice have been used for this purpose, but only limited amounts of blood can be obtained and the animals are (often) sacrificed during the experiment. This paper describes the development of a rabbit model for use as a continuous source of highly labelled erythrocytes as an alternative to mice and rats. A chinchilla rabbit was serially injected with 59Fecitrate to maintain a level of labelling of 12 x 10 5 cpm/ml of blood. During the 42-month use of the chinchilla rabbit, a total of 190 MBq was injected and a total of 277 ml blood was withdrawn. During the whole period, the health of the animal was not affected and no important changes were found in any of the haematological parameters studied. The protocol was successfully applied with a second rabbit with the same results. Our model provides a simple continuous source of highly labelled erythrocytes, minimizing the number of animals otherwise needed for this type of experiment.
monocytes and monocyte-derived macrophages, radioactively-labelled erythrocytes have to be available. 59Fe-Iabelled red blood cells (RBC) have been previously obtained from rats and mice (Lipschitz et al. 1971 , Kleber et al. 1978 , Custer et al. 1982 .In these studies, when a high labelling efficiency was required, anaemia was first induced in the animal either chemically or by repeated bleeding: the labelled iron was subsequently administered over a period of 2 to 4 days. As a result, it took a period ranging from 1 to 3 weeks in order to obtain sufficiently labelled RBC. Major disadvantages of the use of these animals are the Correspondence to: Prof Dr f. f. M. Marx, University Hospital Utrecht, Department of Internal Medicine, Postnr. G02.228, PO Box 85500, 3508 GA Utrecht, The Netherlands. Tel: 31-30-2507394, Fax: 31-30-2518328 length and number of procedures together with the limited amounts of blood that can be acquired from each rat or mouse at any given time including at necropsy.
For studies requiring a continuous source of highly 59Fe-Iabelled RBC a different animal model was needed. Preliminary experiments demonstrated that a minimal activity of 12 x 10 5 counts per minute (cpm) per millilitre of blood was required for studying iron release by monocytes after being loaded with labelled RBC [usually radioactivity of 50 J11 blood is measured e.g. 6 x 10 4 cpm/50 J11 bloodl. Below this value, the activity per sample taken during iron-release experiments was lower than twice the background level. For these experiments it is not possible to use rats, since the amount of RBC needed (4 to 5 ml) exceeds the amount that can be obtained from a single rat. This problem has been overcome by using 59Fe-labelled rabbit erythrocytes in a study of haemoglobin iron absorption in humans, using whole body counting techniques (Liem 1973) .
Therefore, we investigated whether it would be possible to use a rabbit model as a continuous source of highly labelled RBC. A 4000 g rabbit has about 230 ml blood and less than 10% of this volume can be withdrawn every 3 to 4 weeks without affecting the health of the animal (Morton et al. 1993) . After a single i.v. administration of 59Fe, maximum RBC labelling occurs after 3 to 5 days (Neuberger & Niven 1951) . We used this model for 3 years as a continuous source of highly labelled rabbit red blood cells (RRBCj for studying erythrophagocytosis and iron release by monocytes (Moura et al. 1997) . The health of the animal was monitored during the whole period and haematological and serum iron parameters were assessed. The manipulation of the animal was minimal and during the whole period no signs of diseases such as anaemia or radiationinduced diseases such as leukemia or aplastic anemia were observed.
Materials and methods
The experimental protocol was approved by the local Animal Committee of the Utrecht University, The Netherlands.
Animal and husbundry
During our study a chinchilla rabbit (male, weight 4000 g, age 4 months, supplied by Harlan, Zeist, The Netherlands) was used for a period of 34 months. The rabbit was followed for health effects for an additional 8 months after the last radioactive injection. The animal was housed in a cage of 110 x 60 x 56 cm under the following conditions: humidity 50 to 60%, light for 12h, and music in the background. The animal was fed with standard rabbit breeding and maintainance feed (Hope Farms BV,Woerden, The Netherlands) containing 16 700IU/kg vitamin A, 1600IU/kg vitamin D3, 70mg/kg vitamin E, 11 mg/kg copper, 170 mg/kg iron, 17.8% protein, 3 % crude fat, 16.2% crude fibre, 7.9% minerals and 10% moisture.
285

Animal health
The health status of the animals was monitored by assessing physical parameters such as weight, hair quality and hair loss, mucosal hydration, appetite, diarrhoea, eye lesions and general behaviour such as mobility and reaction to stimuli.
Dosing with radioisotope
To achieve the required labelling of 6 x 10 4 cpm/50 J11 blood, a non-labelled rabbit has to be injected in the marginal ear vein with 9.5 MBq 59Fecitrate followed by another injection of 6.5 MBq 59Fecitrate one week later. To maintain this level of labelling, an injection of 3.5 MBq 59Fecitrate every second week was necessary. During the whole period, the rabbit received 5.7 ± 4.4 MBq 59Fe citrate per month for a period of 34 months with a minimum of 1.85 MBq and a maximum of 10MBq (specific activity, 0.15-0.44 MBq/ J1g iron, Amersham, 's-Hertogenbosch, The Netherlands). The total amount of radioactive substance administered was 190 MBq containing 348.6 J1g of iron. The rabbit was surveyed for an additional period of 8 months (a total of 42 months) during which no radioactive substance was injected, but the animal was exposed to the radioactivity of a second rabbit, which was housed in a separate cage 30 cm from the first cage. During this 8-month period this rabbit received an average of 6.6±2.1 MBq per month with a minimum of 3.5 MBq and maximum of 9.5 MBq (total of 50.8 MBq containing 214 J1g of ironl.
Blood collection
Blood was collected from the marginal ear vein one week after the injection with the radioactive substance. During the whole 3year period, blood was withdrawn 58 times from the animal with an average volume of 4.9 ± 2.6 ml (range 1 to 10 mIl and a total volume of 277 ml. The time period between the bleedings was 20 ± 30 days (range 7 to 180 days). When required, blood could be withdrawn every week (done 12 times, divided over a number of periods). Blood was collected in tubes containing (dipotassium) EDTA to prevent clotting. When serum was needed, blood was collected into a tube containing polystyrene granules to promote blood clotting.
Measurement of radioactivity
The labelling of the rabbit was assessed by measuring 59Feactivity of 50 It! EDTA blood. 59Fe activity was measured in an automatic y-counter (PW4800, Phillips, Almelo, The Netherlands). To increase the sensitivity, iron activity was measured at y-emission of 0.05 to 1.9 MeV. With this broad spectrum the two major photon peaks of 59Fe(1.10 and 1.29MeV), a smaller photon peak (0.19MeV) and the Compton area (0.4--1.0MeV) were measured. Each sample was measured until a 2%0" was reached (2%0"=2*lOOIJ~countsl and results were expressed as cpm. The labelling efficiency of the RRBC was calculated by the following formula: [(radioactivity in 50 It! of blood corrected for decay of 59Fex total volume blood rabbit)/ (radioactivity injected)] x 100%.
Haematology, iron, and total iron binding capacity
Blood parameters such as white blood cell (WBC) count and distribution, RBC count, haemoglobin (Hb), haematocrit (Hct), mean cell volume (MCV) and blood platelets were measured in an automatic cell counter (Cell-Dyn 1600, SequoIa-Turner; Abbot Diagnostics, Amsterdam, The Netherlands). The cell counter was validated for rabbit cells as described by Davis and Fisher (1991) . Serum was stored at -20°C until iron radioactivity decayed to background levels. Iron was measured in serum by dry chemistry with an Ektachem 950 analyser from Johnson & Johnson, Amersfoort, The Netherlands. Total iron binding capacity (T1BC)was measured by immuno-nephelometry in a Hitachi 911 from Behring (Behringwerke AG, Marburg, Germany) using a goat anti-human transferrin serum, which cross-reacts with rabbit transferrin. TIBC was calculated from immunologically measured transferrin using the formula mg/transferrin x 0.2275 = TIBC pmoljl (Klein Gebbink et al. 1982) . Human and rabbit transferrin share 79% homology on the amino acid level (Carpenter & Broad Moura, Verheul & Marx 1993) . The iron saturation of transferrin (%) was calculated by the formula: (serum iron/TIBC) x 100%.
Results
Health effects
During the total observation period, the rabbit did not show a change in behaviour or signs of physical deterioration such as lethargy, decreased performance, cataract or diarrhoea. Its initial weight, at the age of 4 months, was 4000 g and after 42 months of handling this was 4635 g.
Dosing with radioisotope
Our experiments required a minimal activity of 6 x 10 4 cpm/50 pI blood. This labelling, however, could not be obtained after a single injection of radioactive substance. As a consequence of the first injections the rabbit had a background labelling of 2.4 ± 1.2 MBq.
To determine the amount of radioactivity needed for the second injection, the rabbit was injected with various amounts of radio- nously with different amounts of 59Fecitrate. One week after injection blood was collected on EDTA. Radioactivity of 50 J-li blood samples was measured.
Resultsare expressed as mean ± SD (n = 3, 3, 10, 5 and 9, respectively, for the five groups) Rabbit s9Fe-labeliederythrocytes active substance (Fig 11. Depending on the amount of substance used, levels between 4 to 6 X 10 4 cpm;50 III of blood were achieved. When 9.5 MBq or 6.5 MBq were injected between 80 to 90% of the radioactive substance was incorporated into the RRBC. During the whole period there was no change in the labelling efficiency (data not shown).
Based on the previous experiments the following protocol was developed for labelling the rabbit to the level of 6 x 10 4 cpmj50 It! blood when it had a background labelling of zero: injection with 9.5 MBq 59Fe citrate (labelling after one week 2.6 MBq) followed by another injection of 6.5 MBq 59Fe citrate one week later (labelling after one week 6.0 MBq). To maintain this level of labelling, an injection of 3.5 MBq 59Fecitrate every second week was necessary.
Haematology and iron parameters
Despite the serial blood collections of a total volume of 277 ml during the 42-month period, Hb, RBC count, Hct and MCV remained stable (Fig2, Table 1 ).There was a steady but <00 A 80 287 small decrease in total WBC count through. out the 42-month period lFig 21.The relative percentage of neutrophils slowly increased during the whole period, whereas for the lymphocytes a small decrease was observed (Fig 2) . Platelets were 264 x 10 9 platelets;l before the administration of radioactive substance and 240 x 10 9 platelets;l after 42 months.
The serum iron concentration, TrnC, and iron saturation were also determined. Initially the rabbit had a serum iron concentration of 22.7 /lmoljl, a TIBC of 54.2'lmol;1 with an iron saturation of 51%. These values were 30 ± 6/lmoljl, 49 ± 3 /lmol;l, and 60± 7%, respectively, during the 42-month period. There was no fluctuation of any importance of these values as a result of the repeated bleedings.
Discussion
This model was developed in order to have a continuous source of 59Fe-Iabellederythrocytes that could be used for iron loading of monocytes and monocyte-derived macrophages. A two injection protocol was developed to achieve the minimal activity of 6 x 10 4 cpm/50,ul of whole blood required for our experiments. However, when for other purposes less radioactive erythrocytes are needed, the amount of radioactive substance administered in the second injection should be adapted (Fig 11. For the whole 34-month period stable values for RBC count, Hb, Hct, and MCV were observed (Fig 2, Table 1 ). There were minimal fluctuations in the platelet count but there were changes in WBC, neutrophils and lymphocytes. These values, however, were similar to that of adult New Zealand White and Wild jack rabbits (Table 1) (Kozma et a1. 1974, Jain 19931 . Moreover, the observed changes in WBC, lymphocytes and neutrophil count are probably a consequence of aging. This pattern of changes during aging has been described for dogs, cattle and humans (Jain 1993 , Bruunsgaard et al. 1997 . Therefore, the observed changes are probably not due to the administration of radioactive substance. Iron concentration, TIBC and saturation remained constant during the 42month period despite phlebotomy of a total of 277 ml of blood.
59Fe is an isotope which decays by emission of mainly y-radiation of high energy.
Despite the high activities used and the long period of exposure to radioactive iron for the chinchilla rabbit, and the administration of 59Feduring the growth phase, the animal did not show any sign of developing radiationinduced diseases such as leukemia or aplastic anaemia. The protocol has been successfully applied to a second rabbit (ELCO, female, adult) with the same results.
In conclusion, our model provides an efficient and convenient source of substantial amounts of highly labelled 59 Fe RBC and can be used for extended periods of time without affecting the health of the rabbits. Compared to the use of rats and mice for this purpose, the procedure minimizes the number of animals needed for this type of experiment.
